Drugs / StreptAnova™
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02564237 | Aug 2015 → Mar 2017 | — | Dalhousie University | Unknown | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | StreptAnova | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02564237 ↗ |
| Modality | Vaccine | “StreptAnova™ (Group A streptococcal (GAS) vaccine)” NCT02564237 ↗ |